Prognostic values of inflammation and immune-based scores in patients with hepatocellular carcinoma who undergo transarterial chemoembolization

被引：0
|
作者：
Cho, Eun Ju [1 ]
Yu, Su Jong [1 ]
Cho, Hyeki [1 ]
Kang, Seong Hee [1 ]
Cho, Young Youn [1 ]
Lee, Jeong-Hoon [1 ]
Kim, Yoon Jun [1 ]
Yoon, Jung-Hwan [1 ]
机构：
[1] Seoul Natl Univ Hosp, Internal Med, Seoul, South Korea
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1321
引用
收藏
页码：661A / 661A
页数：1
相关论文
共 50 条
  • [1] Prognostic Values of Inflammation-Based Scores and Fibrosis Markers in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Cho, Eun Ju
    Yu, Su Jong
    Lee, Yun Bin
    Lee, Jeong-Hoon
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    DIAGNOSTICS, 2022, 12 (05)
  • [2] Prognostic factors of hepatocellular carcinoma patients treated by transarterial chemoembolization
    Xiao, Jun
    Li, Guojian
    Lin, Shuhan
    He, Ke
    Lai, Hao
    Mo, Xianwei
    Chen, Jiansi
    Lin, Yuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (03): : 1114 - 1123
  • [3] Transarterial chemoembolization in patients with hepatocellular carcinoma: who are the best candidates?
    Bouattour, Mohamed
    Abdel-Rehim, Mohamed
    Goutte, Nathalie
    Vullierme, Marie-Pierre
    Faivre, Sandrine
    Raymond, Eric
    Valla, Dominique
    Castera, Laurent
    Vilgrain, Valerie
    Farges, Olivier
    HEPATOLOGY, 2012, 56 : 449A - 450A
  • [4] Transarterial chemoembolization for patients with hepatocellular carcinoma
    Forner, Alejandro
    Real, M. Isabel
    Varela, Maria
    Bruix, Jordi
    HEPATOLOGY RESEARCH, 2007, 37 : S230 - S237
  • [5] Survival outcome of hepatocellular carcinoma patients who underwent transarterial chemoembolization
    Corneja, Anna Lyn
    Que, Ernesto
    Morabe, Ferdinand
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A51 - A52
  • [6] The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy
    He, Tian
    Xu, Bin
    Wang, Lu-Na
    Wang, Zi-Yi
    Shi, Huan-Chen
    Zhong, Cheng-Jie
    Zhu, Xiao-Dong
    Shen, Ying-Hao
    Zhou, Jian
    Fan, Jia
    Sun, Hui-Chuan
    Hu, Bo
    Huang, Cheng
    BIOMARKER RESEARCH, 2025, 13 (01)
  • [7] Evaluation of ART Scores for Repeated Transarterial Chemoembolization in Japanese Patients with Hepatocellular Carcinoma
    Arizumi, Tadaaki
    Ueshima, Kazuomi
    Iwanishi, Mina
    Minami, Tomohiro
    Chishina, Hirokazu
    Kono, Masashi
    Takita, Masahiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Ida, Hiroshi
    Minami, Yasunori
    Sakural, Toshiharu
    Nishida, Naoshi
    Kitano, Masayuki
    Kudo, Masatoshi
    ONCOLOGY, 2015, 89 : 4 - 10
  • [8] An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma
    Pinato, David J.
    Sharma, Rohini
    TRANSLATIONAL RESEARCH, 2012, 160 (02) : 146 - 152
  • [9] Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinoma
    Inokuchi, Shoichi
    Itoh, Shinji
    Yoshizumi, Tomoharu
    Morinaga, Akinari
    Toshima, Takeo
    Takeishi, Kazuki
    Nagao, Yoshihiro
    Harada, Noboru
    Ikegami, Toru
    Shimokawa, Mototsugu
    Mori, Masaki
    LANGENBECKS ARCHIVES OF SURGERY, 2021, 406 (03) : 773 - 779
  • [10] Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinoma
    Shoichi Inokuchi
    Shinji Itoh
    Tomoharu Yoshizumi
    Akinari Morinaga
    Takeo Toshima
    Kazuki Takeishi
    Yoshihiro Nagao
    Noboru Harada
    Toru Ikegami
    Mototsugu Shimokawa
    Masaki Mori
    Langenbeck's Archives of Surgery, 2021, 406 : 773 - 779
12345